RLMD - RELMADA THERAPEUTICS, INC.
0.3439
-0.013 -3.867%
Share volume: 612,599
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.01
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 22.988 M | 18.819 M | 23.009 M | 19.076 M | |
| Selling general and admin | 9.683 M | 8.098 M | 11.860 M | 8.076 M | |
| Research and development | 13.305 M | 10.721 M | 11.149 M | 11.000 M | |
| Total expenses | 22.988 M | 18.819 M | 23.009 M | 19.076 M | |
| -18.14% | 22.27% | -17.09% | |||
| Operating income | -22.988 M | -18.819 M | -23.009 M | -19.076 M | |
| Ebit | -22.884 M | -18.731 M | -22.582 M | -19.312 M | |
| Pretax income | -21.828 M | -17.768 M | -21.726 M | -18.657 M | |
| -18.60% | 22.27% | -14.13% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -21.828 M | -17.768 M | -21.726 M | -18.657 M | |
| 18.60% | -22.27% | 14.13% |
